Nivolumab After Surgery and Chemotherapy in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer (An ALCHEMIST Treatment Trial)
Are you eligible to participate in this study?
You may be eligible for this study if you meet the following criteria:
Conditions: Stage IB Lung Non-Small Cell Carcinoma AJCC v7
Age: Between 18 - 80 Years
Gender: Male or Female
Contact the research team to learn more about this study.
Fields marked with asterisk (*) are required